Boots Centre for Innovation appoints scientific advisor, link to industry
This article was originally published in Clinica
The UK's Boots Centre for Innovation has appointed James Ellis as a second, concurrent scientific advisor, in a move that is said to respond to a "huge response from innovators". His remit will be to work, alongside existing scientific advisor Ryan Bamsey, with business development managers, academics and industry to identify new product opportunities and encourage entrepreneurs to bring their pioneering ideas forward. Having worked for a number of university spin-out companies, Dr Ellis is said to have a "thorough knowledge of the difficulties entrepreneurs often face in finding a route to market". The Swansea, Wales-based Boots Centre for Innovation was set up in 2007 to identify and facilitate the development of pioneering healthcare products, and claims to have received more than 400 proposals.
You may also be interested in...
Informa Pharma Intelligence has officially launched the seventh Global Generics & Biosimilars Awards, which will take place in October 2020 in Milan, Italy.
Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus situation in China, generics industry leader Mylan came under pressure about the potential impact on its business.
Government advisory committee gives initial nod to what will become Japan’s most expensive single drug, but reimbursement pricing could come in for close scrutiny.